Case report: rechallenge with egfr–tkis after immunotherapy in egfr–mutated non–small cell lung cancer with leptomeningeal metastasis

HIGHLIGHTS

• who: Chunfa Qian and colleagues from the Osaka Habikino Medical Center, Japan University of Cagliari, Italy have published the research: Case report: Rechallenge with EGFRu2013TKIs after immunotherapy in EGFRu2013mutated nonu2013small cell lung cancer with leptomeningeal metastasis, in the Journal: (JOURNAL)
• what: The authors report two cases to evaluate the effectiveness of EGFR-TKIs rechallenge in EGFR-mutated NSCLC patients with LM after TKI failure and interspersed immunotherapy.
• how: The treatment history and gene test results are presented in Figure 2D. progressed. The NGS results showed that EGFR L858R mutation TP53 exon 8 missense . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.